查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1528051

核醫學影像設備的全球市場

Nuclear Medicine Imaging Equipment
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 267 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年全球核醫影像設備市場預計將達到45億美元

2023年全球核醫影像設備市場估計為31億美元，預計2030年將達45億美元，2023-2030年分析期間複合年成長率為5.7%。單光子發射電腦斷層掃描 (SPECT) 系統是本報告分析的細分市場之一，預計複合年成長率為 6.1%，到分析期結束時將達到 22 億美元。在分析期間，混合正子掃描 (PET) 系統領域的複合年成長率預計為 5.8%。

美國市場預計將達8.101億美元，中國預計複合年成長率為8.7%

2023年美國核醫影像設備市場預估為8.101億美元。中國作為全球第二大經濟體，預計2030年市場規模將達到10億美元，2023年至2030年的分析期間複合年成長率為8.7%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 3.4% 和 4.6%。在歐洲，德國的複合年成長率預計為 4.2%。

全球核子醫學影像設備市場—主要趨勢與促進因素總結

為什麼核醫學影像設備在現代醫療保健中至關重要？

核子醫學影像設備透過提供對於準確診斷和治療計劃至關重要的內部結構和功能的詳細影像，在現代醫療保健中發揮重要作用。這些設備，例如正子斷層掃描 (PET) 掃描儀和單光子發射斷層掃描 (SPECT) 系統，利用少量放射性物質來視覺化生理過程。這可以及早發現癌症、心血管疾病和神經系統疾病等疾病。與其他診斷影像方式不同，核醫技術能夠評估組織和器官的解剖學和功能方面，為制定有效的治療策略提供必要的全面見解。核醫學影像能夠在分子層面上檢測異常，通常有助於早期診斷。

技術進步如何形塑核子醫學影像設備？

技術進步顯著提高了核醫學影像設備的能力和應用。檢測器技術的創新，例如固體檢測器的開發，提高了影像解析度和靈敏度，從而實現更精確和準確的成像。 PET/CT 和 SPECT/CT 等混合成像技術的整合將核醫學的功能性影像能力與電腦斷層掃描 (CT) 的解剖細節融為一體，提供了更全面的診斷工具。此外，影像處理軟體和人工智慧 (AI) 的進步正在簡化影像分析和解釋，使其更快、更準確。這些技術進步不僅提高了核醫影像的診斷準確性，還擴大了其在個人化醫療中的應用，即根據對患者獨特疾病概況的詳細了解來客製化治療方案。

核子醫學掃描術診斷有哪些新趨勢和創新？

核醫學影像市場正在見證一些正在改變其面貌的新趨勢和創新。一個顯著的趨勢是放射性藥物的使用增加，這是一種含有放射性同位素的藥物，用於診斷和治療。新型放射性藥物的開發正在擴大核醫可診斷和治療的疾病範圍，包括各類癌症和慢性病。另一個主要趨勢是擴大採用數位 PET 和 SPECT 系統，與傳統類比系統相比，這些系統可提供更高的影像品質並縮短掃描時間。分子成像的興起也值得注意。分子成像使生物體內的細胞和分子過程可視化，為更精確和有針對性的治療鋪平了道路。此外，核醫學影像與磁振造影（MRI）等其他診斷方式的整合正在創建多模態影像平台，可以更全面地了解患者的健康狀況。

推動核醫影像設備市場成長的因素有哪些？

核醫學影像設備市場的成長受到多種因素的推動。首先，癌症和心血管疾病等慢性病的盛行率不斷上升，推動了對能夠進行早期準確檢測的先進診斷工具的需求。技術進步，包括混合成像系統的開發以及人工智慧在影像分析中的整合，正在使核醫學成像更加高效和方便。放射性藥物擴大用於診斷和治療應用也是擴大核子醫學範圍的重要驅動力。此外，對個人化醫療的日益重視正在推動核醫學成像技術的採用，該技術可以提供對疾病的分子和功能方面的詳細了解。監管支援和有利的報銷政策使醫療保健提供者和患者更容易獲得這些先進的成像技術，從而推動市場成長。最後，對醫療基礎設施的投資增加以及對核子醫學掃描術診斷益處的認知不斷提高，進一步推動了市場擴張，這些先進的診斷工具在現代醫療保健中繼續發揮重要作用。

受訪企業範例（共29家）

  • Digirad Corporation
  • GE Healthcare
  • Mediso Medical Imaging Systems
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP-1228

Global Nuclear Medicine Imaging Equipment Market to Reach US$4.5 Billion by 2030

The global market for Nuclear Medicine Imaging Equipment estimated at US$3.1 Billion in the year 2023, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Single-Photon Emission Computed Tomography (SPECT) Systems, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Hybrid Positron Emission Tomography (PET) Systems segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$810.1 Million While China is Forecast to Grow at 8.7% CAGR

The Nuclear Medicine Imaging Equipment market in the U.S. is estimated at US$810.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Nuclear Medicine Imaging Equipment Market - Key Trends and Drivers Summarized

Why Is Nuclear Medicine Imaging Equipment Essential in Modern Healthcare?

Nuclear medicine imaging equipment plays a crucial role in contemporary healthcare by providing detailed images of the body’s internal structures and functions, which are vital for accurate diagnosis and treatment planning. These devices, such as positron emission tomography (PET) scanners and single-photon emission computed tomography (SPECT) systems, utilize small amounts of radioactive materials to visualize physiological processes. This allows for the early detection of diseases, including cancer, cardiovascular diseases, and neurological disorders. Unlike other imaging modalities, nuclear medicine techniques can assess both the anatomical and functional aspects of tissues and organs, providing comprehensive insights that are essential for formulating effective treatment strategies. The ability of nuclear medicine imaging to detect abnormalities at the molecular level often leads to earlier diagnosis, which is critical for improving patient outcomes and managing diseases more effectively.

How Are Technological Advancements Shaping Nuclear Medicine Imaging Equipment?

Technological advancements are significantly enhancing the capabilities and applications of nuclear medicine imaging equipment. Innovations in detector technology, such as the development of solid-state detectors, have improved image resolution and sensitivity, enabling more precise and accurate imaging. The integration of hybrid imaging technologies, such as PET/CT and SPECT/CT, combines the functional imaging capabilities of nuclear medicine with the anatomical detail of computed tomography (CT), offering a more comprehensive diagnostic tool. Furthermore, advances in image processing software and artificial intelligence (AI) are streamlining image analysis and interpretation, making it faster and more accurate. These technological improvements not only enhance the diagnostic accuracy of nuclear medicine imaging but also expand its use in personalized medicine, where treatments are tailored based on detailed insights into the patient’s specific disease profile.

What Are the Emerging Trends and Innovations in Nuclear Medicine Imaging?

The nuclear medicine imaging market is witnessing several emerging trends and innovations that are poised to transform its landscape. One prominent trend is the increasing use of radiopharmaceuticals, which are drugs that contain radioactive isotopes used in both diagnosis and treatment. The development of new radiopharmaceuticals is expanding the range of conditions that can be diagnosed and treated with nuclear medicine, including various types of cancer and chronic diseases. Another significant trend is the growing adoption of digital PET and SPECT systems, which offer enhanced image quality and reduced scan times compared to traditional analog systems. The rise of molecular imaging is also noteworthy, as it allows for the visualization of cellular and molecular processes in living organisms, paving the way for more precise and targeted therapies. Additionally, the integration of nuclear medicine imaging with other diagnostic modalities, such as magnetic resonance imaging (MRI), is creating multi-modal imaging platforms that provide a more holistic view of the patient’s health.

What Factors Are Driving the Growth in the Nuclear Medicine Imaging Equipment Market?

The growth in the nuclear medicine imaging equipment market is driven by several factors. Firstly, the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, is fueling the demand for advanced diagnostic tools that can provide early and accurate detection. Technological advancements, including the development of hybrid imaging systems and the integration of AI in image analysis, are making nuclear medicine imaging more efficient and accessible. The expanding use of radiopharmaceuticals in both diagnostic and therapeutic applications is also a significant driver, as it broadens the scope of nuclear medicine. Additionally, the rising emphasis on personalized medicine is driving the adoption of nuclear imaging techniques that offer detailed insights into the molecular and functional aspects of diseases. Regulatory support and favorable reimbursement policies are facilitating market growth by making these advanced imaging technologies more accessible to healthcare providers and patients. Lastly, increasing investments in healthcare infrastructure and the growing awareness about the benefits of nuclear medicine imaging are further propelling the market’s expansion, ensuring that these advanced diagnostic tools continue to play a vital role in modern healthcare.

Select Competitors (Total 29 Featured) -

  • Digirad Corporation
  • GE Healthcare
  • Mediso Medical Imaging Systems
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Nuclear Medicine Imaging Equipment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Spurs Growth in Nuclear Medicine Imaging Equipment Market
    • Technological Advancements in Detector Technology Propel Market Expansion
    • Development of New Radiopharmaceuticals Expands Addressable Market Opportunity
    • Hybrid Imaging Technologies Strengthens Business Case for Integrated Diagnostic Solutions
    • Adoption of Digital PET and SPECT Systems Drives Market Growth
    • Growing Focus on Molecular Imaging Generates Demand for Advanced Nuclear Medicine Equipment
    • Integration with AI and Image Processing Software Enhances Diagnostic Accuracy and Drives Adoption
    • Increasing Awareness and Acceptance of Nuclear Medicine Imaging Drives Adoption
    • Emerging Applications in Oncology and Cardiology Sustain Growth in Market Demand
    • Advances in Non-Invasive Imaging Technologies Propel Growth in Diagnostic Capabilities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nuclear Medicine Imaging Equipment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Single-Photon Emission Computed Tomography (SPECT) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Single-Photon Emission Computed Tomography (SPECT) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Single-Photon Emission Computed Tomography (SPECT) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hybrid Positron Emission Tomography (PET) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hybrid Positron Emission Tomography (PET) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Hybrid Positron Emission Tomography (PET) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Planar Scintigraphy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Planar Scintigraphy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Planar Scintigraphy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • JAPAN
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • CHINA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • EUROPE
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • FRANCE
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • GERMANY
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • INDIA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • AFRICA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030

IV. COMPETITION